Last reviewed · How we verify
CMG901
At a glance
| Generic name | CMG901 |
|---|---|
| Sponsor | Keymed Biosciences Co.Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 (PHASE2)
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |